- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic trades patent charges with Lunar
Turnabout is fair playfor bone densitometry firm Hologic. The Waltham, MA, company raisedthe stakes this month in its legal battle with Lunar, filing acountersuit that accuses its competitor of infringing on its patents.The suit seeks to have three Lunar
Turnabout is fair playfor bone densitometry firm Hologic. The Waltham, MA, company raisedthe stakes this month in its legal battle with Lunar, filing acountersuit that accuses its competitor of infringing on its patents.The suit seeks to have three Lunar patents invalidated.
Lunar, of Madison, WI, fired the opening salvo last month whenit filed a federal lawsuit in U.S. District Court for the EasternDistrict of Wisconsin (SCAN 9/14/94). Lunar said that Hologic'smorphometry process is covered by three Lunar patents and askedthe court to overturn several Hologic patents.
Hologic's countersuit, filed in U.S. District Court for theDistrict of Massachusetts, charges that Lunar is infringing ontwo of Hologic's patents and asks for injunctive relief and damages.The complaint also seeks a declaration that Hologic does not infringeon three Lunar patents, which should be invalidated, accordingto the company. Finally, Hologic is asking for injunctive reliefand damages in connection with what the company said was "Lunar'sdissemination of false and misleading information which misrepresentsand disparages the quality of Hologic's bone densitometry products."
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
